Meril has received ICMR approval for its rapid antigen self-testing test for Covid-19, CoviFind. The test gives results in 15 minutes, Meril said in a statement.
(Photo: Merillife.com)
Medtech company Meril has announced that it has received approval from the Indian Council of Medical Research (ICMR) for its rapid antigen test kit for self-use for Covid-19.
Meril’s indigenous rapid home antigen test kits, CoviFind, will expand access to Covid-19 testing while helping the nation meet the demand for increased and frequent screenings to contain the spread of the pandemic, Meril said in a statement .
The test gives results quickly and gives accurate results in 15 minutes, he added.
“By providing reliable rapid antigen tests for everyone in a convenient format, Meril’s CoviFind test will facilitate early detection, isolation, treatment and contact tracking,” said Sanjeev Bhatt, senior vice-president (corporate strategy) of Meril.
Meril said it has provided a large number of tests for its Covid-19 diagnostic offerings across India, including a multiplex RT-PCR test and Kavach antibody tests in partnership with ICMR.
What does the test include?
The test kit comes with test supplies like a test device, a sterile nasal swab, and a pre-filled buffer tube with a cap, and costs Rs 250 as an affordable single pack, according to the company.
The test kits will be available in retail pharmacies, e-pharmacies and through e-commerce platforms like Amazon and Flipkart in two weeks, she added.
Also read | Setback for Covaxin, US FDA says no to emergency use and suggests “full approval”
Also read | You can correct errors in your Covid vaccination card. Here’s how
Click here for IndiaToday.in’s full coverage of the corona pandemic.
एक टिप्पणी भेजें